Market Overview:
The global long-term mechanical circulatory support (LT-MCS) market is expected to register a CAGR of 7.5% during the forecast period, 2018–2030. The LT-MCS market is segmented on the basis of type, application and region. On the basis of type, the LT-MCS market is segmented into extracorporeal membrane oxygenation device (ECMO), extracorporeal ventricular assist device (EVD) and others. The ECMO segment is expected to account for a major share in terms of revenue in 2018 and is projected to register a CAGR of 8% during the forecast period. On the basis of application, hospitals are estimated to account for a major share in terms of revenue in 2018 and are projected to register a CAGRof 7%.
 Industry Outlook.svg)
Product Definition:
A long-term mechanical circulatory support (LT-MCS) device is a medical device used to assist in the pumping of blood throughout the body. An LT-MCS may be used as a short-term measure to support patients who are awaiting a heart transplant, or it may be used as a long-term treatment for patients with end stage heart failure. The use of an LT-MCS can improve the quality of life for patients with end stage heart failure and may extend their life span.
Extracorporeal Membrane Oxygenation Device:
Extracorporeal Membrane Oxygenation (ECMO) is a procedure wherein the body's natural respiratory process is used to provide an artificial lung by creating a connection between the venous and arterial systems of the patient. The Extracorporeal Membrane Oxygenator (ECMO) device works by taking advantage of the patient’s own biological processes, which include breathing and cardiopulmonary bypass.
Extracorporeal Ventricular Assist Device:
Extracorporeal ventricular assist device (ECVAD) is a machine that helps in recirculating blood outside of the body and provides support for the heart when it cannot pump sufficient blood volume to meet the metabolic demands of the body. The ECVAD market is expected to grow at a significant rate during forecast period owing to increasing prevalence of cardiovascular diseases, rising geriatric population base, and technological advancements pertaining to this field.
Application Insights:
The hospitals segment dominated the market in 2017 and is expected to continue its dominance over the forecast period. This can be attributed to factors such as availability of advanced healthcare facilities, a large patient base with cardiac disorders, presence of key manufacturers and research institutes that provide ongoing support for new product development, and increasing awareness among patients regarding mechanical circulatory support systems.
The others application segment includes care at home or other facility-based settings. Patients suffering from respiratory failure or brain injury may require long-term mechanical circulatory support at home without being admitted in an intensive care unit (ICU). Such patients are candidates for remote monitoring through telemedicine so that they can receive necessary treatment without having to go through the rigmarole of visiting a hospital every day. The others segment is anticipated to witness significant growth over the forecast period owing to rising incidences of cardiovascular diseases as well as traumatic brain injuries across various regions globally.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure, high awareness levels coupled with relatively higher healthcare expenditure levels and a large number of product launches are some factors attributing to its largest share. In addition, increasing demand for organ transplantation procedures is also expected to drive the growth over the forecast period.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to improving healthcare facilities and rising disposable income especially in developing countries such as India and China. Furthermore, an increase in cardiac surgeries due to better diagnosis & treatment options will boost demand further over this period. Moreover, growing medical tourism industry will also contribute towards regional growth during future years (i).
The European region followed North America with considerable market shares owing their developed economies along with comparatively higher health care spending levels (ii).
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing geriatric population
- Rising demand for minimally invasive surgeries
- Technological advancements in LT-MCS devices
- Increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Long-term Mechanical Circulatory Support (LT-MCS) Market Research Report
By Type
Extracorporeal Membrane Oxygenation Device, Extracorporeal Ventricular Assist Device, Others
By Application
Hospitals, Specialized Cardiac Centers, Ambulatory Surgery centers, Others
By Companies
Abbott Laboratories, LivaNova, Nipro Corporation, Terumo Corporation, Medtronic, BiVACOR, Evaheart, Abiomed
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Long-term Mechanical Circulatory Support (LT-MCS) Market Report Segments:
The global Long-term Mechanical Circulatory Support (LT-MCS) market is segmented on the basis of:
Types
Extracorporeal Membrane Oxygenation Device, Extracorporeal Ventricular Assist Device, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialized Cardiac Centers, Ambulatory Surgery centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- LivaNova
- Nipro Corporation
- Terumo Corporation
- Medtronic
- BiVACOR
- Evaheart
- Abiomed
 Market Overview.svg)
Highlights of The Long-term Mechanical Circulatory Support (LT-MCS) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Extracorporeal Membrane Oxygenation Device
- Extracorporeal Ventricular Assist Device
- Others
- By Application:
- Hospitals
- Specialized Cardiac Centers
- Ambulatory Surgery centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Long-term Mechanical Circulatory Support (LT-MCS) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
LT-MCS is a long-term mechanical circulatory support (LTCS) therapy that helps to maintain blood flow and oxygen levels in the body. It is typically used to help people with heart failure or other conditions that cause decreased blood flow. LT-MCS can also be used to help people who have undergone surgery or who are recovering from an illness.
Some of the major players in the long-term mechanical circulatory support (lt-mcs) market are Abbott Laboratories, LivaNova, Nipro Corporation, Terumo Corporation, Medtronic, BiVACOR, Evaheart, Abiomed.
The long-term mechanical circulatory support (lt-mcs) market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Long-term Mechanical Circulatory Support (LT-MCS) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Long-term Mechanical Circulatory Support (LT-MCS) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Long-term Mechanical Circulatory Support (LT-MCS) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Long-term Mechanical Circulatory Support (LT-MCS) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Long-term Mechanical Circulatory Support (LT-MCS) Market Size & Forecast, 2018-2028
4.5.1 Long-term Mechanical Circulatory Support (LT-MCS) Market Size and Y-o-Y Growth
4.5.2 Long-term Mechanical Circulatory Support (LT-MCS) Market Absolute $ Opportunity
Chapter 5 Global Long-term Mechanical Circulatory Support (LT-MCS) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Type
5.2.1 Extracorporeal Membrane Oxygenation Device
5.2.2 Extracorporeal Ventricular Assist Device
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Long-term Mechanical Circulatory Support (LT-MCS) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialized Cardiac Centers
6.2.3 Ambulatory Surgery centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Long-term Mechanical Circulatory Support (LT-MCS) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Long-term Mechanical Circulatory Support (LT-MCS) Analysis and Forecast
9.1 Introduction
9.2 North America Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Type
9.6.1 Extracorporeal Membrane Oxygenation Device
9.6.2 Extracorporeal Ventricular Assist Device
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialized Cardiac Centers
9.10.3 Ambulatory Surgery centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Long-term Mechanical Circulatory Support (LT-MCS) Analysis and Forecast
10.1 Introduction
10.2 Europe Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Type
10.6.1 Extracorporeal Membrane Oxygenation Device
10.6.2 Extracorporeal Ventricular Assist Device
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialized Cardiac Centers
10.10.3 Ambulatory Surgery centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Long-term Mechanical Circulatory Support (LT-MCS) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Type
11.6.1 Extracorporeal Membrane Oxygenation Device
11.6.2 Extracorporeal Ventricular Assist Device
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialized Cardiac Centers
11.10.3 Ambulatory Surgery centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Long-term Mechanical Circulatory Support (LT-MCS) Analysis and Forecast
12.1 Introduction
12.2 Latin America Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Type
12.6.1 Extracorporeal Membrane Oxygenation Device
12.6.2 Extracorporeal Ventricular Assist Device
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialized Cardiac Centers
12.10.3 Ambulatory Surgery centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Long-term Mechanical Circulatory Support (LT-MCS) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Type
13.6.1 Extracorporeal Membrane Oxygenation Device
13.6.2 Extracorporeal Ventricular Assist Device
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Long-term Mechanical Circulatory Support (LT-MCS) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialized Cardiac Centers
13.10.3 Ambulatory Surgery centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Long-term Mechanical Circulatory Support (LT-MCS) Market: Competitive Dashboard
14.2 Global Long-term Mechanical Circulatory Support (LT-MCS) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 LivaNova
14.3.3 Nipro Corporation
14.3.4 Terumo Corporation
14.3.5 Medtronic
14.3.6 BiVACOR
14.3.7 Evaheart
14.3.8 Abiomed
